• Dry Cracked Skin
  • General Dermatology
  • Impetigo
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

An Unwavering Commitment to Innovation

News
Article
Dermatology TimesDermatology Times, January 2024 (Vol. 45. No. 01)
Volume 45
Issue 01

Dermatology Times is excited to ring in 2024 with a fresh perspective to amplify our impact, foster creativity, and deliver even more exceptional, compelling content to you—our cherished audience.

wavebreak3/Adobe Stock
wavebreak3/Adobe Stock

Change is the essence of growth and, just like you, our readers, Dermatology Times embraces new challenges and innovation to find the best way to deliver and present top-quality content. With that in mind, we are excited to ring in 2024 with a fresh perspective for the Editor in Chief role, with quarterly model to amplify our impact, foster creativity, and deliver even more exceptional, compelling content to you—our cherished audience. After careful consideration, we have invited some of the brightest thought leaders in the field to help ensure Dermatology Times remains the top news source for those providing dermatologic care.

To kick off the new year, Christopher Bunick, MD, PhD, associate professor of dermatology and physician-scientist at the Yale School of Medicine in New Haven, Connecticut, will share his insights and perspectives as our Editor in Chief in January, February, and March. His first letter looks ahead to 2024 and resolutions for novice and seasoned dermatology clinicians.

Later this year, Editorial Advisory Board members Aaron Farberg, MD; Shanna Miranti, MPAS, PA-C; and Raj Chovatiya, MD, PhD; will share their perspectives in dermatologic care as our Editor in Chief .

We want to express our sincere gratitude to Editor in Chief Emeritus Zoe Diana Draelos, MD, for her dedication and enthusiasm, as well as the continuation of her highly anticipated Cosmetic Conundrums column. Rest assured, Dr Draelos will continue to share her insights as a valued member of our Editorial Advisory Board.

Dermatology Times will continue its long-standing tradition to publish innovative research and treatment solutions for a variety of disease states, practice management tools, and challenging cases to unravel. To keep the momentum going, we will also debut new columns, sections, and writers throughout the year.

To keep up with the latest updates in breaking news, treatment pearls, study data, and interviews with experts in the field, subscribe to Dermatology Times e-newsletters, follow us on social media, and email us with ideas and feedback at DTEditor@mmhgroup.com.

Together, we will continue to inspire, inform, and innovate to propel patient care and the field of dermatology. Thank you for your continued readership.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.